Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium lactate versus 3% saline in septic shock
2024-517927-37-00Phase 2Authorised
- Sponsor
- Fakultní nemocnice Plzeň
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Sodium lactate and sodium chloride in septic shock and sepsis (2 arms), sponsored by Fakultní nemocnice Plzeň. Primary endpoint: Change in cardiac stroke work. Planned start Nov 2024; status: authorised.
02
Drugs
Sodium lactatesodium chloride
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on 2024-517927-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517927-37-00.